Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey C Umotoy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|July 19, 2021
Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 CureJeffrey C Umotoy, Steven W de Taeye
Angewandte Chemie (International Ed. in English)|January 13, 2015
Nitrosopurines en route to potently cytotoxic asmarinesKanny K Wan, Kotaro Iwasaki, Jeffrey C Umotoy, et al.
ACS Chemical Biology|August 1, 2014
Selective inhibition of initiator versus executioner caspases using small peptides containing unnatural amino acidsChris J Vickers, Gonzalo E González-Páez, Kevin M Litwin, et al.
Chembiochem : a European Journal of Chemical Biology|July 10, 2013
Small-molecule procaspase activators identified using fluorescence polarizationChris J Vickers, Gonzalo E González-Páez, Jeffrey C Umotoy, et al.
ACS Central Science|July 15, 2016
Synthesis and Sulfur Electrophilicity of the Nuphar Thiaspirane PharmacophoreNorihiro Tada, Daniel J Jansen, Matthew P Mower, et al.
Communications Biology|August 9, 2024
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killingSteven W de Taeye, Angela I Schriek, Jeffrey C Umotoy, et al.
Iscience|October 11, 2024
Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9Jeffrey C Umotoy, Pascal Z Kroon, Shirley Man, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
Plant Biotechnology Journal|November 20, 2024
Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacySteven W de Taeye, Loïc Faye, Bertrand Morel, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|July 19, 2021
Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 CureJeffrey C Umotoy, Steven W de Taeye
Angewandte Chemie (International Ed. in English)|January 13, 2015
Nitrosopurines en route to potently cytotoxic asmarinesKanny K Wan, Kotaro Iwasaki, Jeffrey C Umotoy, et al.
ACS Chemical Biology|August 1, 2014
Selective inhibition of initiator versus executioner caspases using small peptides containing unnatural amino acidsChris J Vickers, Gonzalo E González-Páez, Kevin M Litwin, et al.
Chembiochem : a European Journal of Chemical Biology|July 10, 2013
Small-molecule procaspase activators identified using fluorescence polarizationChris J Vickers, Gonzalo E González-Páez, Jeffrey C Umotoy, et al.
ACS Central Science|July 15, 2016
Synthesis and Sulfur Electrophilicity of the Nuphar Thiaspirane PharmacophoreNorihiro Tada, Daniel J Jansen, Matthew P Mower, et al.
Communications Biology|August 9, 2024
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killingSteven W de Taeye, Angela I Schriek, Jeffrey C Umotoy, et al.
Iscience|October 11, 2024
Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9Jeffrey C Umotoy, Pascal Z Kroon, Shirley Man, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
Plant Biotechnology Journal|November 20, 2024
Plant-produced SARS-CoV-2 antibody engineered towards enhanced potency and in vivo efficacySteven W de Taeye, Loïc Faye, Bertrand Morel, et al.
Pageof 2